Abstract |
The eukaryotic initiation factor-2B (eIF-2B) can regulate translation and protein synthesis. We used Western blot analysis to quantify the protein level of the catalytic epsilon (epsilon) subunit of eIF-2B in brains of rats fed lithium chloride (LiCl) for 6 weeks so as to produce a brain lithium concentration that is therapeutically effective in bipolar disorder. The ratio of eIF-2B (epsilon) to actin protein was significantly reduced (P<0.01) in LiCl-fed rats, 0.86+/-0.06 (SE) compared to 1.2+/-0.07 in control rats. These results suggest that a therapeutic level of lithium may downregulate the synthesis of proteins whose translation depends on eIF-2B.
|
Authors | Francesca Bosetti, Ruth Seemann, Stanley I Rapoport |
Journal | Neuroscience letters
(Neurosci Lett)
Vol. 327
Issue 1
Pg. 71-3
(Jul 12 2002)
ISSN: 0304-3940 [Print] Ireland |
PMID | 12098503
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Antimanic Agents
- Eukaryotic Initiation Factor-2B
- Lithium Chloride
|
Topics |
- Animals
- Antimanic Agents
(pharmacology)
- Bipolar Disorder
(drug therapy, metabolism)
- Brain
(drug effects, metabolism)
- Brain Chemistry
(drug effects)
- Eukaryotic Initiation Factor-2B
(metabolism)
- Lithium Chloride
(pharmacology)
- Male
- Protein Biosynthesis
(drug effects)
- Rats
- Rats, Inbred F344
|